Structured Notes Quietly Regain Shelf Space in Advisor Portfolios

The Quiet Return of a Complicated Product

Structured notes – those hybrid debt instruments that bundle market exposure with built-in downside buffers – spent several years on the margins of advisor conversations. Rising rates, product complexity complaints, and a general preference for simpler vehicles pushed them aside. Now they’re coming back, and the reasons say something worth paying attention to about how advisors are thinking about risk right now.

Why Structured Notes Fell Out of Favor – And Why That’s Changing

The core mechanics of a structured note haven’t changed. An investor buys a bank-issued note that links returns to some underlying benchmark – often an equity index – while offering partial or full principal protection up to a defined threshold. The bank uses the investor’s capital to purchase a bond (which funds the protection) and options contracts (which fund the upside participation). The investor gives up some or all dividends, accepts issuer credit risk, and agrees to hold through a fixed term, typically one to seven years.

For years, the knock against them was cost opacity. The embedded fee structure – baked into the terms rather than listed as a line item – made it genuinely difficult for clients to understand what they were paying. Regulators flagged disclosure issues, and a number of high-profile suitability disputes involving structured products broadly left a reputational stain on the category. Fee-conscious RIAs, many of them built on a transparent, fiduciary model, largely walked away.

What’s shifted is partly the rate environment. When short-term rates were near zero, the bond component of a structured note couldn’t generate enough yield to fund meaningful principal protection without gutting the participation rate. The math just didn’t work in investors’ favor. With rates elevated, the bond sleeve of the structure produces real income, which means issuers can now offer more attractive combinations – deeper buffers, higher participation rates, or shorter durations – without sacrificing one to fund the other. The product architecture genuinely performs better in this rate environment than it did in 2019 or 2020.

There’s also a behavioral dimension that advisors are being more direct about. Clients who stayed invested through 2022 – a year in which both equities and bonds fell hard – came away with a specific and persistent anxiety: that diversification alone doesn’t protect against everything. Structured notes with defined buffers offer something psychologically concrete. A client can see, in plain terms, that the first 15% of index losses are absorbed before they feel any impact. That clarity has real value in client conversations, even when the underlying mechanics remain complex.

How Advisors Are Actually Using Them Now

The way structured notes are being deployed has changed as much as the reasons for deploying them. A product that was once sold as a standalone equity alternative is now more commonly slotted into a specific role within a broader allocation. Advisors are treating them less like a core holding and more like a precision tool – used to replace a portion of defensive equity exposure where a client needs market participation but genuinely cannot stomach a full drawdown.

Buffer notes tied to the S&P 500 or a similar broad index are the most common version being discussed. In a typical structure, the note might offer 100% participation in index gains up to a cap – say, 15% to 20% over 12 to 18 months – while absorbing the first 10% to 20% of losses. The cap limits upside, which is the explicit trade-off, and the credit risk of the issuing bank sits quietly in the background. That issuer risk gets more attention now than it did before 2008, and most advisors working with these instruments stick to large, highly-rated financial institutions.

Some advisors are pairing structured notes with ETF-based strategies to create what amounts to a tiered risk structure within a single client account. The ETFs handle liquidity and low-cost market access, while the structured note handles the portion of the allocation where the client’s loss tolerance is most limited. It’s not an approach that works for everyone – it adds complexity and requires the advisor to actively monitor maturity dates and reinvestment timing – but for clients in or near retirement, the combination can address a very specific tension between growth needs and capital preservation.

Liquidity remains the honest objection. Structured notes don’t trade on an exchange the way a bond ETF does. Secondary market pricing is controlled by the issuing bank, and early redemption can mean accepting a price that reflects neither the original terms nor current market value. For clients who might need access to capital on short notice, that illiquidity is a real and meaningful constraint – not a footnote. Advisors who are using these products responsibly are building them into accounts where the client has sufficient liquid reserves held elsewhere.

There’s also a product literacy gap that hasn’t fully closed. The advisors incorporating structured notes today tend to be those who have spent time understanding the term sheet mechanics – how participation rates are set, what “buffer” means versus “barrier,” what happens to the note if the issuer’s credit rating drops. That’s a higher baseline of product knowledge than many client-facing advisors maintain for more standard instruments, and it limits the category’s reach. A product that requires extensive advisor education to use responsibly isn’t going to become a mainstream allocation tool any time soon.

The Tension That Won’t Resolve

The fundamental tension with structured notes is that they solve a real problem – investor anxiety about downside risk in volatile equity markets – using a mechanism that is genuinely difficult to evaluate. Comparing two competing notes from different issuers requires modeling the embedded option values, the issuer spread, the opportunity cost of the dividend give-up, and the realistic probability of hitting the cap. Most clients cannot do that analysis, and many advisors are working from issuer-provided materials that have an obvious interest in favorable presentation.

That doesn’t make structured notes bad. It makes them context-dependent in a way that demands advisor judgment rather than product selection criteria alone. The question worth sitting with: if a client needs this level of downside protection, is a structured note the most cost-effective and transparent way to get it, or does the answer involve a different portfolio construction entirely?